Search
PAVmed Inc
PAVMAdd to Watchlist
2.170USD
+0.120+5.85%
Close 10-23 16:00（ET）
17.36MMarket Cap
LossP/E TTM
PAVmed Inc (PAVM) Stock Price Target & Forecast
Analyst Rating
Based on 2 analysts giving stock ratings to PAVmed Inc in the past month.
Buy
0 Strong Buy
2 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
36.500USD+1414.52%
PAVM Analyst Recommendation Trends
In the current month, PAVM has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PAVM average Analyst price target in the last month is 36.500.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
PAVM Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
14
9
1
0
35
Boston Scientific Corp
BSX
9
17
8
0
0
34
Thermo Fisher Scientific Inc
TMO
11
16
4
0
0
31
Edwards Lifesciences Corp
EW
10
15
6
0
0
31
Veeva Systems Inc
VEEV
8
14
7
1
0
30
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
10
7
0
0
23
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, PAVM EPS is projected to reach -0.590 in FY2026Q3, following reported EPS of -0.874 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-5.40
-0.70
-0.47
-0.59
-0.56
Actual
-2.05
-4.42
-0.87
--
--
Surprise
+62.10%
-531.51%
-85.94%
--
--
FAQs
What is PAVmed Inc's expected revenue for the next quarter?
PAVmed Inc's expected revenue is 25.00K.
What is PAVmed Inc's price target?
Analysts forecast that PAVmed Inc's price target is USD 36.50, with the highest forecast at USD 57.00 and the lowest forecast at USD 16.00.
How have PAVmed IncPAVM's recent earnings per share performed?
The market expectation was USD -0.87, while PAVmed IncPAVM's earnings per share (EPS) for the previous quarter was USD -4.42. EPS for the next quarter is expected at USD -0.59.
What is the analyst rating for PAVmed Inc?
Based on the ratings of PAVmed Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.